ABSTRACT
KEY POINTS • All women should be offered aneuploidy screening, ide-
ally starting in the rst trimester. Population screening should have genetic counseling services available to discuss the different modalities, advantages and disadvantages, and the time frame for each test prior to screening. All women should have counseling available if desired or if an “abnormal” result occurs. The difference between a screening and a diagnostic test should be clearly explained before any testing.
